Adrenal Disorders High‑Yield Guide for Gulf Prometric Exams (DHA, SMLE, HAAD, MOH)

Why Master Adrenal Disorders for Gulf Licensing Exams?

Endocrine emergencies and chronic adrenal diseases are a staple of the DHA, SMLE, HAAD, and MOH exam blueprints. Questions often focus on classic presentations, diagnostic algorithms, and the nuances of pharmacologic management. A solid grasp of adrenal physiology not only boosts your exam score but also prepares you for real‑world practice in the Gulf’s multicultural patient population.

Exam Blueprint Snapshot

• Core topics: Addison’s disease, primary & secondary adrenal insufficiency, Cushing’s syndrome, ectopic ACTH, adrenal incidentaloma, pheochromocytoma, and paraganglioma.
• Key competencies: Interpretation of cortisol & ACTH testing, imaging selection, peri‑operative management, and drug‑drug interactions (e.g., ketoconazole, metyrapone).
• Question formats: Single best answer MCQs, clinical vignette cases, and algorithm‑based “step‑wise” questions.

High‑Yield Content Overview

1. Primary Adrenal Insufficiency (Addison’s Disease)

Classic triad: Hyperpigmentation, hypotension, and hyperkalemia. In the Gulf, autoimmune adrenalitis accounts for ~70% of cases, while TB remains a notable cause in expatriate populations.

• Screening test: 8‑am serum cortisol < 3 µg/dL (80 nmol/L) or > 18 µg/dL (500 nmol/L) rules out disease.
• Confirmatory test: 250 µg ACTH (cosyntropin) stimulation – a rise < 18 µg/dL at 30 min confirms insufficiency.
• Treatment: Hydrocortisone 15‑25 mg/day divided (morning and afternoon) + fludrocortisone 0.05‑0.1 mg daily.
• Stress dosing: Double oral dose for minor stress, 100 mg IV hydrocortisone bolus for major surgery or trauma.

2. Secondary Adrenal Insufficiency

Resulting from pituitary or hypothalamic dysfunction (e.g., pituitary macroadenoma, chronic steroid therapy). Key differences from primary disease:

• Low/normal ACTH.
• Absence of hyperpigmentation and typically normal potassium.
• Cosyntropin test may be normal early in the disease; repeat after 6‑12 weeks if suspicion persists.

Management: Gradual taper of glucocorticoids, replace with hydrocortisone (10‑15 mg/m²) if symptomatic.

3. Cushing’s Syndrome

Excess cortisol from any source. Distinguish ACTH‑dependent (pituitary adenoma – Cushing’s disease; ectopic ACTH) from ACTH‑independent (adrenal adenoma, carcinoma).

• First‑line screening: 24‑hr urinary free cortisol (UFC) > 2× ULN, late‑night salivary cortisol, or 1‑mg dexamethasone suppression test (DST) – cortisol > 1.8 µg/dL (50 nmol/L) suggests Cushing’s.
• Confirmatory: High‑dose DST (8‑mg) – suppression > 50% points to pituitary source.
• Imaging pathway: Pituitary MRI if ACTH‑dependent; adrenal CT/MRI if ACTH‑independent.
• Treatment: Transsphenoidal surgery for pituitary tumors; adrenalectomy for unilateral adenoma; medical therapy (ketoconazole, metyrapone, osilodrostat) when surgery contraindicated.

4. Pheochromocytoma & Paraganglioma

Catecholamine‑secreting tumors that can masquerade as hypertension, anxiety, or panic attacks—common in Gulf expatriates with undiagnosed familial syndromes (MEN‑2, VHL).

• Biochemical confirmation: Plasma free metanephrines or 24‑hr urinary metanephrines – values > 2× ULN are diagnostic.
• Pre‑operative preparation: Alpha‑blockade (phenoxybenzamine 10‑20 mg q6h) for 10‑14 days, then beta‑blocker (propranolol) if tachycardia persists.
• Surgical approach: Laparoscopic adrenalectomy for most tumors; open surgery for large (> 6 cm) or invasive lesions.

5. Adrenal Incidentaloma

Incidental adrenal mass ≥ 1 cm found on CT/MRI. Management hinges on hormonal activity and malignancy risk.

• Hormonal work‑up: Overnight dexamethasone suppression, plasma metanephrines, aldosterone/renin ratio (if hypertensive).
• Imaging criteria for surgery: Size > 4 cm, Hounsfield units > 10 on non‑contrast CT, or rapid growth (> 1 cm/yr).
• Follow‑up: Repeat imaging at 6‑12 months if < 4 cm and non‑functional.

Clinical Pearls for the Exam

• Hyperpigmentation only occurs in primary adrenal insufficiency because of excess ACTH.
• “Moon face, buffalo hump, and central obesity” = Cushing’s syndrome. Remember that a normal potassium does NOT exclude Cushing’s.
• Rule out pheochromocytoma before any adrenal surgery** – missing this is a classic exam trap.
• In secondary adrenal insufficiency, the adrenal glands are atrophic; thus, the ACTH stimulation test may be normal early on.
• Fludrocortisone is only needed in primary adrenal insufficiency** because aldosterone production is lost.